Australasian radiology最新文献

A case is presented here of Castleman disease in an uncommon location. Ultrasonography demonstrated a large hypoechoic mass with multiple vascular channels. On computed tomography, the lesions with a nodular contour were located lateral to the carotid sheath on the right side, and demonstrated a variegated enhancement pattern.

Recent reports in the Australian media have claimed that after the Second World War 'hundreds of (Australians) were injected with radioactive materials in medical experiments that continued in Australian hospitals until the 1960s'. These claims prompted a review of archival records of the Australian Radiation Laboratory (ARL) that are held by the Australian Archives pertaining to the medical uses of radio-isotopes during the period 1947-73. The material examined indicates that the procurement, distribution, and therapeutic and diagnostic uses of radio-isotopes were stringently controlled by the Radio-isotopes Standing committee (RSC) until 1973, when the responsibility of regulation of medical uses of radio-isotopes passed to the Therapeutic Goods Administration. On the basis of available information it appears that the claims made by the media that many Australians were subjected to unconscionable medical experiments are unjustified. A full report has been released by the Commonwealth Minister for Human Services and Health. The following is an abridged version of that report, detailing some of the more contentious uses of radio-isotopes for medical purposes in Australia during the period 1947-73.

A young man presented with desmoplastic fibroma in the proximal ulna. This rare tumour was treated by curettage and bone grafting.

Over a 3-year period, four cases of maxillary osteoradionecrosis were diagnosed in patients undergoing radiotherapy for nasopharyngeal carcinoma at the Queen Mary Hospital, Hong Kong, giving an estimated incidence of 0.8%. Patients with this complication presented after a mean period of 34 months post-radiotherapy. Risk factors that were identified were dental problems, and more than one full course of radical radiotherapy. Serial CT scans in the axial and coronal planes were useful in demonstrating the development, extent and features of maxillary osteoradionecrosis such as bony sclerosis, the destruction of maxillary antral walls and adjacent bony structures, and in excluding recurrent tumour.

Skin-sparing properties of megavoltage photon beams are compromised by electron contamination. Higher energy beams do not necessarily produce lower surface and basal cell layer doses due to this electron contamination. For a 5 x 5 cm field size the surface doses for 6 MVp and 18 MVp X-ray beams are 10% and 7% of their respective maxima. However, at a field size of 40 x 40 cm the percentage surface dose is 42% for both 6 MVp and 18 MVp beams. The introduction of beam modifying devices such block trays can further reduce the skin-sparing advantages of high energy photon beams. Using a 10 mm perspex block tray, the surface doses for 6 MVp and 18 MVp beams with a 5 x 5 cm field size are 10% and 8%, respectively. At 40 x 40 cm, surface doses are 61% and 63% for 6 MVp and 18 MVp beams, respectively. This trend is followed at the basal cell layer depth. At a depth of 1 mm, 18 MVp beam doses are always at least 5% smaller than 6 MVp doses for the same depth at all field sizes when normalized to their respective Dmax values. Results have shown that higher energy photon beams produce a negligible reduction of the delivered dose to the basal cell layer (0.1 mm). Only a small increase in skin sparing is seen at the dermal layer (1 mm), which can be negated by the increased exit dose from an opposing field.

Encouraging survival and tumour marker results have been described in patients where the focally destructive technique, hepatic cryotherapy, is used to treat primary and secondary hepatic malignancy. Radiology allows assessment of the cryotherapy procedure and follow-up treatment. This paper aims to review and describe the appearance of hepatic cryotherapy by CT.

The association of cerebral arteriovenous malformations and intracranial aneurysms has been well documented. Among these are a subset of giant aneurysms in association with arteriovenous malformations which are relatively rare. We present a case report and a brief review of the literature regarding this entity.